Does RISANKIZUMAB Cause Inflammation? 18 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Inflammation have been filed in association with RISANKIZUMAB (Skyrizi). This represents 0.7% of all adverse event reports for RISANKIZUMAB.
18
Reports of Inflammation with RISANKIZUMAB
0.7%
of all RISANKIZUMAB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Inflammation From RISANKIZUMAB?
Of the 18 reports, 10 (55.6%) required hospitalization.
Is Inflammation Listed in the Official Label?
Yes, Inflammation is listed as a known adverse reaction in the official FDA drug label for RISANKIZUMAB.
What Other Side Effects Does RISANKIZUMAB Cause?
Product storage error (396)
Drug ineffective (206)
Psoriasis (138)
Crohn's disease (103)
Arthralgia (100)
Off label use (100)
Product temperature excursion issue (88)
Diarrhoea (72)
Fatigue (70)
Rash (64)
What Other Drugs Cause Inflammation?
ADALIMUMAB (7,754)
METHOTREXATE (5,055)
ETANERCEPT (4,459)
RITUXIMAB (3,540)
SECUKINUMAB (3,515)
INFLIXIMAB (3,448)
TOCILIZUMAB (3,371)
ABATACEPT (3,284)
TOFACITINIB (3,241)
LEFLUNOMIDE (3,067)
Which RISANKIZUMAB Alternatives Have Lower Inflammation Risk?
RISANKIZUMAB vs RISANKIZUMAB-RZAA
RISANKIZUMAB vs RISDIPLAM
RISANKIZUMAB vs RISEDRONATE
RISANKIZUMAB vs RISEDRONIC ACID
RISANKIZUMAB vs RISPERDAL